Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma

Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma

Zhenfeng Zhu,1,2,* Litao Xu,1,2,* Liping Zhuang,1,2 Zhouyu Ning,1,2 Chenyue Zhang,1,2 Xia Yan,1,2 Junhua Lin,1,2 Yehua Shen,1,2 Peng Wang,1,2 Zhiqiang Meng1,2 1Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; 2Department of Oncology, Shanghai Medi...

Full description

Bibliographic Details
Main Authors: Zhu Z, Xu L, Zhuang L, Ning Z, Zhang C, Yan X, Lin J, Shen Y, Wang P, Meng Z
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:OncoTargets and Therapy
Subjects:
hepatocellular carcinoma
sorafenib
biomarker
monocyte to lymphocyte ratio
prognosis
Online Access:https://www.dovepress.com/role-of-monocyte-to-lymphocyte-ratio-in-predicting-sorafenib-response--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/role-of-monocyte-to-lymphocyte-ratio-in-predicting-sorafenib-response--peer-reviewed-article-OTT

Similar Items